PC
BIIB icon

Prairiewood Capital’s Biogen BIIB Stock Holding History

Prairiewood Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,920
Closed -$1.7M – 69
2021
Q2 		$1.7M Sell
4,920
-286
-5% -$86.6K 1.46% 18
2021
Q1 		$1.46M Buy
5,206
+373
+8% +$101K 1.34% 19
2020
Q4 		$1.18M Buy
+4,833
New +$1.25M 1.21% 22

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Prairiewood Capital's BIIB Position: Q3 2021 in Review

Prairiewood Capital sold out of Biogen (BIIB) in Q3 2021, closing a stake of 4,920 shares — an estimated $1.7M sold.

Prairiewood Capital first reported a position in BIIB in Q4 2020 and held it in 3 quarters. The position peaked at $1.7M in Q2 2021. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Prairiewood Capital reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Prairiewood Capital sold 4,920 Biogen shares in Q3 2021, an estimated $1.7M.
  • Prairiewood Capital first reported a position in Biogen in Q4 2020 and held it in 3 quarters.
  • Prairiewood Capital's Biogen position peaked at $1.7M in Q2 2021.
  • 1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Prairiewood Capital's 13F filing for Q3 2021, filed 13 Oct 2021.